NAUT - Nautilus Biotechnology - Stock Forecast

Coverage Performance Price Targets & Ratings Chart Insider Trading

NAUT is currently covered by 2 analysts with an average price target of $3.62. This is a potential upside of $1.22 (50.83%) from yesterday's end of day stock price of $2.4.

Nautilus Biotechnology's activity chart (see below) currently has 3 price targets and 7 ratings on display. The stock rating distribution of NAUT is 100% HOLD.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 30% with an average time for these price targets to be met of 71 days.

Highest price target for NAUT is $6, Lowest price target is $3, average price target is $3.62.

Most recent stock forecast was given by TEJAS SAVANT from MORGAN STANLEY on 03-Aug-2023. First documented stock forecast 04-Aug-2021.

Best performing analysts who are covering NAUT - Nautilus Biotechnology:

Matthew Sykes Tejas Savant

Currently out of the existing stock ratings of NAUT, 5 are a HOLD (100%).

Analyst name

Rating

Current price target

Potential distance

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Hold

6

$3.58 (147.93%)

6

8 months 21 days ago

0/2 (0%)

$2.86 (91.08%)

Hold

3

$0.58 (23.97%)

2

9 months 10 days ago

3/5 (60%)

$-0.42 (-12.28%)

142

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is NAUT (Nautilus Biotechnology) average time for price targets to be met?

On average it took 71 days on average for the stock forecasts to be realized with a an average price target met ratio 30

Which analyst has the current highest performing score on NAUT (Nautilus Biotechnology) with a proven track record?

MATTHEW SYKES

Which analyst has the current lower performing score on NAUT (Nautilus Biotechnology) with a proven track record?

TEJAS SAVANT

Which analyst has the most public recommendations on NAUT (Nautilus Biotechnology)?

Matthew Sykes works at GOLDMAN SACHS and has 4 price targets and 3 ratings on NAUT

Which analyst is the currently most bullish on NAUT (Nautilus Biotechnology)?

Tejas Savant with highest potential upside - $3.58

Which analyst is the currently most reserved on NAUT (Nautilus Biotechnology)?

Matthew Sykes with lowest potential downside - $0.58

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?